{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-010740","form_type":"8-K","ticker":"HROW","cik":"0001360214","company_name":"HARROW, INC.","filed_at":"2024-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.947936+00:00","generated_at":"2026-06-04T09:43:08.215712+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CMS increases MUE for Harrow's IHEEZO J-Code from 1 to 2, effective July 2024 retroactive to Jan 1, 2024","bullets":["CMS approved increase of Medically Unlikely Edit (MUE) for IHEEZO J-Code J2403 from 1 to 2 units.","Change allows billing for two vials of IHEEZO, supporting bilateral ocular procedures.","Effective July 2024, with retroactive application to procedures from January 1, 2024.","Company requested the change in February 2024 citing ophthalmologist need for bilateral use."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-010740","json":"https://secwatch.observer/filing/0001493152-24-010740.json","markdown":"https://secwatch.observer/filing/0001493152-24-010740.md","text":"https://secwatch.observer/filing/0001493152-24-010740.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224010740/0001493152-24-010740-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224010740/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:43:08.215712+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}